Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits.
Journal
Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
27
01
2022
accepted:
22
07
2022
revised:
16
07
2022
pubmed:
11
8
2022
medline:
15
12
2022
entrez:
10
8
2022
Statut:
ppublish
Résumé
Common variation in the gene encoding the neuron-specific RNA splicing factor RNA Binding Fox-1 Homolog 1 (RBFOX1) has been identified as a risk factor for several psychiatric conditions, and rare genetic variants have been found causal for autism spectrum disorder (ASD). Here, we explored the genetic landscape of RBFOX1 more deeply, integrating evidence from existing and new human studies as well as studies in Rbfox1 knockout mice. Mining existing data from large-scale studies of human common genetic variants, we confirmed gene-based and genome-wide association of RBFOX1 with risk tolerance, major depressive disorder and schizophrenia. Data on six mental disorders revealed copy number losses and gains to be more frequent in ASD cases than in controls. Consistently, RBFOX1 expression appeared decreased in post-mortem frontal and temporal cortices of individuals with ASD and prefrontal cortex of individuals with schizophrenia. Brain-functional MRI studies demonstrated that carriers of a common RBFOX1 variant, rs6500744, displayed increased neural reactivity to emotional stimuli, reduced prefrontal processing during cognitive control, and enhanced fear expression after fear conditioning, going along with increased avoidance behaviour. Investigating Rbfox1 neuron-specific knockout mice allowed us to further specify the role of this gene in behaviour. The model was characterised by pronounced hyperactivity, stereotyped behaviour, impairments in fear acquisition and extinction, reduced social interest, and lack of aggression; it provides excellent construct and face validity as an animal model of ASD. In conclusion, convergent translational evidence shows that common variants in RBFOX1 are associated with a broad spectrum of psychiatric traits and disorders, while rare genetic variation seems to expose to early-onset neurodevelopmental psychiatric disorders with and without developmental delay like ASD, in particular. Studying the pleiotropic nature of RBFOX1 can profoundly enhance our understanding of mental disorder vulnerability.
Identifiants
pubmed: 35948661
doi: 10.1038/s41380-022-01722-4
pii: 10.1038/s41380-022-01722-4
pmc: PMC9734045
doi:
Substances chimiques
RBFOX1 protein, human
0
RNA Splicing Factors
0
Rbfox1 protein, mouse
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4464-4473Subventions
Organisme : Eesti Teadusagentuur (Estonian Research Council)
ID : PRG1213
Informations de copyright
© 2022. The Author(s).
Références
J Cogn Neurosci. 2011 Dec;23(12):4022-37
pubmed: 21671731
Mol Psychiatry. 2016 Apr;21(4):500-8
pubmed: 26122585
Neuron. 2018 Feb 21;97(4):853-868.e6
pubmed: 29398366
Annu Rev Psychol. 2012;63:129-51
pubmed: 22129456
BMC Neurosci. 2008 Oct 21;9:102
pubmed: 18939997
Trends Cogn Sci. 2008 May;12(5):193-200
pubmed: 18403252
Nat Genet. 2011 May 29;43(7):706-11
pubmed: 21623373
Autism Res. 2011 Feb;4(1):5-16
pubmed: 21328568
Biol Psychiatry. 2012 Sep 15;72(6):512-20
pubmed: 22621998
Mol Psychiatry. 2014 Jan;19(1):122-8
pubmed: 23319006
J Psychiatry Neurosci. 2003 Sep;28(5):350-4
pubmed: 14517578
Neuron. 2018 Nov 21;100(4):846-859.e7
pubmed: 30318414
Front Neural Circuits. 2018 May 16;12:37
pubmed: 29867371
Neuropsychopharmacology. 2008 Mar;33(4):901-12
pubmed: 17507914
J Psychopharmacol. 1992 Jan;6(2):176-90
pubmed: 22291349
Neuron. 2016 Jan 6;89(1):113-28
pubmed: 26687839
Neuron. 2018 Apr 4;98(1):127-141.e7
pubmed: 29621484
PLoS One. 2009 Jun 10;4(6):e5865
pubmed: 19517024
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6269-74
pubmed: 16569698
Nat Rev Neurosci. 2010 Jul;11(7):490-502
pubmed: 20559336
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Nat Neurosci. 2005 May;8(5):594-6
pubmed: 15821730
Mol Cytogenet. 2013 Jul 03;6(1):26
pubmed: 23822903
Nature. 2022 Mar;603(7902):654-660
pubmed: 35296861
Neuropsychopharmacology. 2019 Feb;44(3):590-597
pubmed: 30375508
PLoS One. 2015 Aug 14;10(8):e0134865
pubmed: 26274327
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12568-12573
pubmed: 27791105
Nat Neurosci. 2005 Jun;8(6):828-34
pubmed: 15880108
Neuropsychopharmacology. 2013 Feb;38(3):525-32
pubmed: 23132269
Genome Res. 2015 Jan;25(1):1-13
pubmed: 25524026
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
Nat Genet. 2018 Jul;50(7):920-927
pubmed: 29942085
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Neuroimage. 2021 Aug 15;237:118157
pubmed: 34020017
Hum Mol Genet. 2012 Oct 1;21(19):4171-86
pubmed: 22730494
Trends Cogn Sci. 2011 Feb;15(2):85-93
pubmed: 21167765
Nat Rev Neurosci. 2005 Jul;6(7):533-44
pubmed: 15995724
Genes Dev. 2001 Apr 1;15(7):859-76
pubmed: 11297510
JAMA Psychiatry. 2014 May;71(5):531-9
pubmed: 24622944
Elife. 2019 Aug 20;8:
pubmed: 31429825
Am J Hum Genet. 2016 Jan 7;98(1):58-74
pubmed: 26749308
Schizophr Bull. 2017 Sep 1;43(5):1114-1122
pubmed: 28207073
Eur Neuropsychopharmacol. 2020 Jan;30:44-55
pubmed: 29174947
Neuroimage. 2002 Sep;17(1):317-23
pubmed: 12482086
Am J Psychiatry. 2020 Sep 1;177(9):855-866
pubmed: 32600152
Am J Psychiatry. 2018 Jan 1;175(1):15-27
pubmed: 28969442
Am J Psychiatry. 2020 Mar 1;177(3):254-264
pubmed: 31838872
Biol Psychiatry. 2007 Nov 15;62(10):1191-4
pubmed: 17707349
Nature. 2009 Oct 8;461(7265):747-53
pubmed: 19812666
Mol Autism. 2015 Jul 07;6:43
pubmed: 26185613
Sci Rep. 2020 Feb 21;10(1):3198
pubmed: 32081867
JAMA Psychiatry. 2016 Jun 1;73(6):598-605
pubmed: 27145286
Hum Brain Mapp. 2019 Dec 15;40(18):5202-5212
pubmed: 31441562
Biol Psychiatry. 2020 Jul 15;88(2):169-184
pubmed: 31926635
Mol Psychiatry. 2019 Nov;24(11):1655-1667
pubmed: 29858598
Autism Res. 2016 Jan;9(1):9-16
pubmed: 26052927